腹膜透析相关性腹膜炎的临床治疗进展  

Therapeutic advances of peritoneal dialysis-associated peritonitis

作　　者：邓秋 杨陈 安宁 Deng Qiu;Yang Chen;An Ning(Department of Nephrology,Affiliated Hospital,Guangdong Medical College,Zhanjiang 524000,China)

机构地区：[1]广东医科大学附属医院肾内科,湛江524000

出　　处：《临床肾脏病杂志》2024年第10期865-869,共5页Journal Of Clinical Nephrology

基　　金：广东省自然科学基金项目(2023A1515030024,2021A1515011581);湛江市财政资金科技专项竞争性分配项目(2018A01040)。

摘　　要：腹膜透析相关性腹膜炎是终末期肾病患者腹膜透析治疗的主要并发症。反复发生腹膜炎会导致腹膜粘连、增厚,严重者可导致腹膜功能障碍,以至腹膜透析失败,甚至死亡。本文从腹膜透析相关性腹膜炎的定义、流行病学、危险因素以及治疗手段等方面,结合国内外研究前沿进展,对腹膜透析相关性腹膜炎予以综述,为临床诊治提供理论依据。Peritoneal dialysis-associated peritonitis is a major complication of peritoneal dialysis(PD)in patients with end-stage renal disease(ESRD).Recurrent peritonitis may lead to peritoneal adhesions and thickening.In severe cases,it results in peritoneal failure so that PD fails with greater morbidity and mortality.Here the definition,epidemiology,risk factors and treatments of peritoneal dialysis-associated peritonitis were summarized with the latest domestic and international researches to provide theoretical rationales for optimized clinical management.

关 键 词：腹膜透析 腹膜透析相关性腹膜炎 危险因素 治疗 

分 类 号：R692.5[医药卫生—泌尿科学] R572.2[医药卫生—外科学]